Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Clinical trial NCT06088004 · RECRUITING

Trial details

NCT number: NCT06088004
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-09-28
Primary completion: 2026-12-30
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.